Gareth Morgan, MD, PhD

Gareth Morgan, MD, PhD, the director of the Myeloma Institute at the University of Arkansas, discusses gene expression profiling for patients with smoldering myeloma.

Smoldering myeloma doesn&rsquo;t act as a single disease.

Gene expression profiling, a clinical staging system based on four genes, is used as an approach to identify high-risk progression of this disease. It is also used as technique to determine which patients would progress in one year.

Intervention studies or treatments can be used following gene expression profiling.

Gareth Morgan, MD, PhD | Authors

Articles

Gene Expression Profiling for Smoldering Myeloma Patients